APYX vs CB · rev $48.1M vs P/E 14, rev $59.40B
Apyx Medical Inc (APYX) versus Chubb Ltd (CB) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
APYX currently screens at market cap $179.6M. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Not investment advice. Open the APYX and CB stock pages for the full models.
Not investment advice.